🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/11/2008 | 43,87 | 45,15 | 43,50 | 45,01 | +3,20% | 3,75% | 822.000 |
| 31/10/2008 | 42,49 | 44,13 | 42,01 | 43,62 | +3,23% | 5,00% | 1.220.600 |
| 30/10/2008 | 40,93 | 42,95 | 40,00 | 42,25 | +6,09% | 7,21% | 1.503.600 |
| 29/10/2008 | 39,10 | 40,74 | 37,52 | 39,83 | +3,81% | 8,25% | 1.913.000 |
| 28/10/2008 | 40,79 | 41,53 | 37,32 | 38,37 | -5,24% | 10,32% | 2.041.800 |
| 27/10/2008 | 43,74 | 44,00 | 40,38 | 40,49 | -8,90% | 8,29% | 1.637.600 |
| 24/10/2008 | 43,61 | 46,05 | 43,06 | 44,44 | -5,28% | 6,86% | 1.128.800 |
| 23/10/2008 | 50,25 | 50,77 | 45,00 | 46,92 | -6,71% | 11,47% | 1.513.200 |
| 22/10/2008 | 50,01 | 52,05 | 49,31 | 50,29 | -0,19% | 5,49% | 986.200 |
| 21/10/2008 | 50,12 | 51,50 | 49,21 | 50,39 | -0,09% | 4,57% | 1.056.600 |
| 20/10/2008 | 48,81 | 50,48 | 47,98 | 50,43 | +4,92% | 5,12% | 807.200 |
| 17/10/2008 | 46,36 | 49,80 | 46,36 | 48,07 | +0,82% | 7,43% | 1.191.800 |
| 16/10/2008 | 45,00 | 47,86 | 43,51 | 47,68 | +5,92% | 9,67% | 1.131.400 |
| 15/10/2008 | 46,64 | 47,77 | 44,99 | 45,01 | -5,36% | 5,96% | 1.031.800 |
| 14/10/2008 | 48,59 | 49,38 | 46,86 | 47,56 | -1,63% | 5,19% | 886.600 |
| 13/10/2008 | 46,28 | 48,37 | 45,69 | 48,35 | +7,00% | 5,79% | 824.400 |
| 10/10/2008 | 44,85 | 45,75 | 41,87 | 45,19 | -1,27% | 8,65% | 1.854.000 |
| 09/10/2008 | 48,22 | 49,98 | 45,34 | 45,77 | -5,41% | 9,61% | 1.155.200 |
| 08/10/2008 | 45,85 | 50,13 | 45,15 | 48,38 | +3,44% | 10,87% | 2.016.800 |
| 07/10/2008 | 47,26 | 48,97 | 46,61 | 46,77 | -1,37% | 4,99% | 1.797.800 |
| 06/10/2008 | 49,37 | 49,48 | 45,15 | 47,42 | -5,68% | 8,77% | 1.848.000 |
| 03/10/2008 | 52,25 | 52,34 | 49,78 | 50,28 | -3,30% | 4,90% | 1.482.200 |
| 02/10/2008 | 53,19 | 53,99 | 51,49 | 51,99 | -1,94% | 4,71% | 1.117.400 |
| 01/10/2008 | 52,58 | 54,18 | 52,58 | 53,02 | +0,83% | 3,05% | 912.200 |
| 30/09/2008 | 52,89 | 53,38 | 52,01 | 52,59 | -0,82% | 2,59% | 992.000 |
| 29/09/2008 | 54,00 | 55,08 | 52,88 | 53,02 | -4,30% | 4,07% | 1.102.600 |
| 26/09/2008 | 55,34 | 56,17 | 53,84 | 55,40 | +0,73% | 4,22% | 922.200 |
| 25/09/2008 | 53,93 | 55,26 | 53,68 | 55,00 | +2,06% | 2,93% | 1.273.000 |
| 24/09/2008 | 54,95 | 54,96 | 53,32 | 53,89 | +0,81% | 2,98% | 738.200 |
| 23/09/2008 | 54,83 | 57,30 | 52,77 | 53,46 | +0,87% | 8,25% | 602.800 |